Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: A Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group

Haematologica

Volumn 93, Issue 10, 2008, Pages 1555-1559

  Fujishima, Naohito ^a   Sawada, Ken Ichi ^a   Hirokawa, Makoto ^a   Oshimi, Kazuo ^b   Sugimoto, Koichi ^b   Matsuda, Akira ^c   Teramura, Masanao ^d   Karasawa, Masamitsu ^e   Arai, Ayako ^f   Yonemura, Yuji ^g   Nakao, Shinji ^h   Urabe, Akio ⁱ   Omine, Mitsuhiro ^j   Ozawa, Keiya ^k  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SAITAMA MEDICAL UNIVERSITY INTERNATIONAL MEDICAL CENTER   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^e GUNMA UNIVERSITY HOSPITAL   (Japan)

^f TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^g KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^h KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

ⁱ Kanto Teishin Hospital   (Japan)

^j SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^k JICHI MEDICAL UNIVERSITY   (Japan)

more..

Author keywords

Cyclophosphamide; Cyclosporine; Large granular lymphocyte leukemia; Pure red cell aplasia

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHOTREXATE; PREDNISOLONE;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ERYTHROCYTE APLASIA; FEMALE; HEALTH SURVEY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JAPAN; LARGE GRANULAR LYMPHOCYTE; LONG TERM CARE; LYMPHATIC LEUKEMIA; MALE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COOPERATIVE BEHAVIOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; JAPAN; LEUKEMIA, LARGE GRANULAR LYMPHOCYTIC; MALE; MIDDLE AGED; RED-CELL APLASIA, PURE; REMISSION INDUCTION; SALVAGE THERAPY; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 54349104206     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.12871     Document Type: Article

References (21)

1. Lacy MQ, Kurtin PJ, Tefferi A. Pure red cell aplasia: association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities. Blood 1996;87: 3000-6.
2. Mamiya S, Itoh T, Miura AB. Acquired pure red cell aplasia in Japan. Eur J Haematol 1997;59:199-205.
3. Sawada K, Hirokawa M, Fujishima N, Teramura M, Bessho M, Dan K, et al. For the PRCA Collaborative Study Group. Long-term relapse-free survival and overall survival of patients with acquired primary idiopathic PRCA receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group. Haematologica 2007;92:1021-8.
4. Semenzato G, Zambello R, Starkebaum G, Oshimi K, Loughran TP Jr. The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood 1997; 89:256-60.
5. Yamada O, Mizoguchi H, Oshimi K. Cyclophosphamide therapy for pure red cell aplasia associated with granular lymphocyte-proliferative disorders. Br J Haematol 1997;97:392-9.
6. Oshimi K, Yamada O, Kaneko T, Nishinarita S, Iizuka Y, Urabe A, et al. Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders. Leukemia 1993;7:782-8.
7. Chan WC, Catovsky D, Foucar K, Montserrat E. T-cell large granular lymphocyte leukaemia: World Health Organization Classification of Tumours. Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon. 2001. p. 197-8.
8. Loughran TP Jr. Clonal diseases of large granular lymphocytes. Blood 1993;82:1-14.
9. Lamy T, Loughran TP. Large granular lymphocyte leukemia. Cancer Control 1998;5:25-33.
10. Go RS, Li CY, Tefferi A, Phyliky RL. Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes. Blood 2001;98:483-5.
11. Go RS, Lust JA, Phyliky RL. Aplastic anemia and pure red cell aplasia associated with large granular lymphocyte leukemia. Semin Hematol 2003;40:196-200.
12. Dhodapkar MV, Li CY, Lust JA, Tefferi A, Phyliky RL. Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance? Blood 1994;84:1620-7.
13. Hirokawa M, Sawada K, Fujishima N, Teramura M, Bessho M, Dan K, et al. For the PRCA Collaborative Study Group. Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia: A Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group. Haematologica 2008;93:27-33.
14. Loughran TP Jr, Starkebaum G. Large granular lymphocyte leukemia. Report of 38 cases and review of the literature. Medicine (Baltimore) 1987;66:397-405.
15. Mori S, Suzushima H, Nishikawa K, Miyake H, Yonemura Y, Tsuji N, et al. Smoldering γδ T-cell granular lymphocytic leukemia associated with pure red cell aplasia. Acta Haematol 1995;94:32-5.
16. Cash JM, Klippel JH. Second-line drug therapy for rheumatoid arthritis. N Engl J Med 1994;330:1368-75.
17. Talar-Williams C, Hijazi YM, Walther MM, Linehan WM, Hallahan CW, Lubensky I, et al. Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis. Ann Intern Med 1996;124:477-84.
18. Reinhold-Keller E, Beuge N, Latza U, de Groot K, Rudert H, Nölle B, et al. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients. Arthritis Rheum 2000; 43:1021-32.
19. Radis CD, Kahl LE, Baker GL, Wasko MC, Cash JM, Gallatin A, et al. Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. A 20-year followup study. Arthritis Rheum 1995;38:1120-7.
20. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488-98.
21. Baker GL, Kahl LE, Zee BC, Stolzer BL, Agarwal AK, Medsger TA Jr. Malignancy following treatment of rheumatoid arthritis with cyclophosphamide. Long-term case-control follow-up study. Am J Med 1987;83:1-9.